Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | EVP, Marketing | March 15, 2021 | March 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date March 15, 2021 · Filed March 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,327 |
Ending reported balance
After 2021-03-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-03-15 · Exercise / conversion · Acquired 7,102 · Balance 44,429 Row 2 · 2021-03-15 · Sale · Disposed 4,050 · Balance 40,379 F1: Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Row 3 · 2021-03-15 · Sale · Disposed 3,052 · Balance 37,327 F2: Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.62 · Expires 2021-03-31 | Direct | 0 |
Reported balance
After 2021-03-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-03-15 · Exercise / conversion · Disposed 7,102 · Balance 0 F3: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2021 Filed Mar 16, 2021 22:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,102 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-21-021080 · doc4.xml · derivative · entry 4 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,102 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 22:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,052 | $52.21 | $159,356.21 |
DisclosureSEC source: 0001209191-21-021080 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,327 F2 · price: Represents the weighted average share price of an aggregate total of 3,052 shares sold in the price range of $52.11 to $52.42 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 22:37 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 4,050 | $51.78 | $209,692.40 |
DisclosureSEC source: 0001209191-21-021080 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,379 F1 · price: Represents the weighted average share price of an aggregate total of 4,050 shares sold in the price range of $51.10 to $52.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 22:37 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 7,102 | $16.62 | $118,035.24 |
DisclosureSEC source: 0001209191-21-021080 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:57 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Units · Derivative | 3,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017158 · doc4.xml · derivative · entry 4 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,763 Underlying: Common Stock · 3,763 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F4 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F4 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2022, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:57 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionRestricted Stock Units · Derivative | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017158 · doc4.xml · derivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,276 Underlying: Common Stock · 1,092 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F3 · derivative.exercise_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F3 · derivative.expiration_date: Subject to the reporting person's continued service, 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:57 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 874 | $53.14 | $46,444.36 |
DisclosureSEC source: 0001209191-21-017158 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,327 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 22:57 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,092 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-017158 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,201 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 00:10 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 76 | $35.28 | $2,681.28 |
DisclosureSEC source: 0001209191-20-061305 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,109 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 00:10 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 66 | $35.28 | $2,328.48 |
DisclosureSEC source: 0001209191-20-061305 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,185 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 00:10 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 107 | $35.28 | $3,774.96 |
DisclosureSEC source: 0001209191-20-061305 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,251 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 76 | $28.94 | $2,199.44 |
DisclosureSEC source: 0001209191-20-049261 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,358 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 66 | $28.94 | $1,910.04 |
DisclosureSEC source: 0001209191-20-049261 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,434 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020. Read SEC document |
| September 01, 2020 Filed Sep 2, 2020 23:11 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 106 | $28.94 | $3,067.64 |
DisclosureSEC source: 0001209191-20-049261 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:26 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 75 | $38.55 | $2,891.25 |
DisclosureSEC source: 0001209191-20-034205 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,606 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:26 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 66 | $38.55 | $2,544.30 |
DisclosureSEC source: 0001209191-20-034205 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,681 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 22:26 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 105 | $38.55 | $4,047.75 |
DisclosureSEC source: 0001209191-20-034205 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,747 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:43 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 340 | $45.78 | $15,565.20 |
DisclosureSEC source: 0001209191-20-015817 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,852 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:43 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 75 | $45.78 | $3,433.50 |
DisclosureSEC source: 0001209191-20-015817 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,192 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 01:43 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 120 | $45.78 | $5,493.60 |
DisclosureSEC source: 0001209191-20-015817 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,267 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2020. Read SEC document |
| February 28, 2020 Filed May 21, 2020 22:38 UTC | Inogen Inc INGN · Entity 2083 | GrantRestricted Stock Units · Derivative | 4,368 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-031457 · doc4.xml · derivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,368 Underlying: Common Stock · 4,368 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Inogen common stock. F2 · derivative.exercise_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. F2 · derivative.expiration_date: 25% of the restricted stock units shall vest on March 1, 2021, and 1/16th of the restricted stock units shall vest every three months thereafter on the 1st day of the month. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:43 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 66 | $73.61 | $4,858.26 |
DisclosureSEC source: 0001209191-19-058927 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,387 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019. Read SEC document |
| December 01, 2019 Filed Dec 4, 2019 02:43 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 106 | $73.61 | $7,802.66 |
DisclosureSEC source: 0001209191-19-058927 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,453 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2019. Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 01:07 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 67 | $46.37 | $3,106.79 |
DisclosureSEC source: 0001209191-19-048411 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,559 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019. Read SEC document |
| September 01, 2019 Filed Sep 5, 2019 01:07 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 107 | $46.37 | $4,961.59 |
DisclosureSEC source: 0001209191-19-048411 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,626 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2019. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:12 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 66 | $64.47 | $4,255.02 |
DisclosureSEC source: 0001209191-19-034602 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,733 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019. Read SEC document |
| June 01, 2019 Filed Jun 5, 2019 01:12 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 106 | $64.47 | $6,833.82 |
DisclosureSEC source: 0001209191-19-034602 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,799 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on June 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 185 | $106.97 | $19,789.45 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 7 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,905 F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 75 | $106.97 | $8,022.75 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 6 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,090 F5 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 319 | $106.97 | $34,123.43 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 5 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,165 F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of a performance-based restricted stock award that was earned and vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 920 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 4 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,484 F4 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2018 performance-based restricted stock award granted on March 2, 2018. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 394 | $106.97 | $42,146.18 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,564 F3 · shares: The reported shares were withheld in a net issuance to cover the Reporting Person's tax withholding liability in connection with the portion of a performance-based restricted stock award that was earned and vested on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 1,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,958 F2 · shares: The reported securities represent shares earned and vested on March 1, 2019 based on achievement of the financial performance conditions for the 2018 fiscal year that were approved as part of the 2017 performance-based restricted stock award granted on August 8, 2017. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:19 UTC | Inogen Inc INGN · Entity 2083 | GrantCommon Stock | 2,430 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016173 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,820 F1 · shares: The reported securities represent shares of restricted stock, 25% of which shall vest on March 1, 2020, and 1/16th of which shall vest every three months thereafter on the 1st day of the month, subject in each case to the reporting person remaining a service provider through each such applicable vesting date. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $0.81 | $0.00 |
DisclosureSEC source: 0001209191-19-000477 · doc4.xml · derivative · entry 2 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,480 Underlying: Common Stock · 14,000 shares Expires 2022-03-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2012. Read SEC document |
| December 31, 2018 Filed Jan 2, 2019 23:54 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 14,000 | $0.81 | $11,340.00 |
DisclosureSEC source: 0001209191-19-000477 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2018 Filed Dec 3, 2018 22:42 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 106 | $147.36 | $15,620.16 |
DisclosureSEC source: 0001209191-18-060641 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,390 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2018. Read SEC document |
| October 17, 2018 Filed Nov 7, 2018 00:08 UTC | Inogen Inc INGN · Entity 2083 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-057468 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,496 Read SEC document |
| September 01, 2018 Filed Sep 5, 2018 20:32 UTC | Inogen Inc INGN · Entity 2083 | Tax withholdingCommon Stock | 446 | $264.91 | $118,149.86 |
DisclosureSEC source: 0001209191-18-049572 · doc4.xml · nonDerivative · entry 1 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,496 F1 · shares: The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on September 1, 2018. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 877 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · derivative · entry 13 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,123 Underlying: Common Stock · 877 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 5,689 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · derivative · entry 12 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 Underlying: Common Stock · 5,689 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 5,054 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · derivative · entry 11 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,054 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013 Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 400 | $231.72 | $92,687.00 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 10 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,942 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F8 · price: Represents the weighted average share price of an aggregate total of 400 shares sold in the price range of $231.53 to $231.84 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 300 | $231.18 | $69,354.99 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 9 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,342 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F7 · price: Represents the weighted average share price of an aggregate total of 300 shares sold in the price range of $230.53 to $231.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,769 | $229.82 | $406,549.63 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 8 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,642 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 1,769 shares sold in the price range of $229.235 to $230.220 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,050 | $228.57 | $468,569.53 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 7 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,411 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 2,050 shares sold in the price range of $228.19 to $229.18 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 5,067 | $227.61 | $1,153,304.94 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 6 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,461 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 5,067 shares sold in the price range of $227.175 to $228.150 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 8,699 | $226.72 | $1,972,279.91 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 5 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,528 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 8,699 shares sold in the price range of $226.16 to $227.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 6,668 | $225.66 | $1,504,716.88 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 4 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,227 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 6,668 shares sold in the price range of $225.15 to $226.14 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 09, 2018 Filed Aug 14, 2018 00:07 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 877 | $38.54 | $33,799.58 |
DisclosureSEC source: 0001209191-18-046520 · doc4.xml · nonDerivative · entry 3 Myers Byron · CIK 0001596086 · EVP, Sales and Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,895 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.